Antidepressants Market Report 2026

Antidepressants Market Overview

• Antidepressants market size has reached to $17.9 billion in 2025 • Expected to grow to $20.54 billion in 2030 at a compound annual growth rate (CAGR) of 2.8% • Growth Driver: Rising Cases Of Mental Illness • Market Trend: Novel Treatment Introduction In The Antidepressant Market • North America was the largest region in 2025 and Middle East is the fastest growing region.

What Is Covered Under Antidepressants Market?

Antidepressants refer to a medication that aids in the treatment of depressive symptoms. Additionally, they can aid in the treatment of SAD, other anxiety disorders, and social anxiety disorder. Unpleasant side effects are possible with antidepressants. Initially, signs and symptoms including nausea, weight gain, or sleep issues can be prevalent. The main product types of antidepressants are selective serotonin reuptake inhibitor (SSRI), serotonin-norepinephrine reuptake inhibitor (SNRI), tricyclic antidepressant (TCA), and monoamine oxidase inhibitor (MAOI). SSRIs (selective serotonin reuptake inhibitors) are a type of medication that is commonly used to treat depression and a few other mental illnesses. The various drug class includes monoamine oxidase inhibitors, serotonin antagonist and reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, selective serotonin reuptake inhibitors, and tricyclic antidepressants that are used for the treatment of the major depressive disorder, obsessive-compulsive disorder, generalized anxiety disorder, and panic disorder.

What Is The Antidepressants Market Growth Forecast?

The antidepressants market size is expected to see steady growth in the next few years. It will grow to $20.54 billion in 2030 at a compound annual growth rate (CAGR) of 2.8%. The growth in the forecast period can be attributed to advancements in precision medicine, integration of ai in mental health diagnostics, rising adoption of digital therapeutics, expansion of telemedicine services, growth in pediatric and geriatric antidepressant demand. Major trends in the forecast period include personalized antidepressant therapy, telepsychiatry & remote mental health services, mobile health apps for mood monitoring, increase in awareness of mental health disorders, rise in geriatric and pediatric depression treatment.

Global Antidepressants Market Segmentation

1) By Product: Selective Serotonin Reuptake Inhibitor (SSRI), Serotonin-norepinephrine Reuptake Inhibitor (SNRI), Tricyclic Antidepressant (TCA), Monoamine Oxidase Inhibitor (MAOI) 2) By Drug Class: Monoamine Oxidase Inhibitors, Serotonin Antagonist And Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, Selective Serotonin Reuptake Inhibitors, Tricyclic Antidepressants 3) By Depressive Disorder: Major Depressive Disorder, Obsessive-Compulsive Disorder, Generalized Anxiety Disorder, Panic Disorder Subsegments: 1) By Selective Serotonin Reuptake Inhibitor (SSRI): Fluoxetine, Sertraline, Escitalopram, Paroxetine, Citalopram 2) By Serotonin-norepinephrine Reuptake Inhibitor (SNRI): Venlafaxine, Duloxetine, Desvenlafaxine 3) By Tricyclic Antidepressant (TCA): Amitriptyline, Nortriptyline, Imipramine, Doxepin 4) By Monoamine Oxidase Inhibitor (MAOI): Phenelzine, Tranylcypromine, Isocarboxazid

What Is The Driver Of The Antidepressants Market?

The increasing mental illness is expected to propel the demand for the antidepressants market going forward. A mental illness is a disorder that impacts the way a person thinks, feels, behaves, or believes. These illnesses occur due to distress or difficulties functioning in social, job, or family activities. Antidepressants are a type of medication used to treat various mental health conditions, including depression, anxiety, and mood disorders. It works by increasing the levels of certain chemicals in the brain that are responsible for regulating mood and emotions. For instance, in October 2025, according to the Care Quality Commission (CQC), a UK-based independent regulator of health and adult social care in England, in 2024/25, there was an average of 453,930 new referrals to secondary mental health services per month a 15% increase compared to 2022/23. Therefore, increasing mental illness will drive the antidepressants industry.

Key Players In The Global Antidepressants Market

Major companies operating in the antidepressants market are Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Novartis AG, Sanofi S.A., Bristol Myers Squibb Company, Abbott Laboratories, AstraZeneca plc, GlaxoSmithKline plc, Takeda Pharmaceutical Co. Ltd., Eli Lilly and Company, Boehringer Ingelheim GmbH, H. Lundbeck AS, Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co., Mylan N.V, Sun Pharmaceuticals Pvt. Ltd., Servier Laboratories, Sumitomo Dainippon Pharma Co., Aurobindo Pharma Limited, Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals plc, Allergan plc, Alkermes plc, Egis Pharmaceuticals plc, Forest Laboratories Inc.

Global Antidepressants Market Trends and Insights

Major companies operating in the antidepressant market are increasing their focus on introducing new drugs such as the ZURZUVAE (zuranolone) for treatment of postpartum depression (PPD) to maximize revenue in the market. Postpartum depression (PPD) is a type of depression that can occur after giving birth. It is a serious mental health condition that can affect both new mothers and fathers. For instance, in August 2023, Biogen Inc a US-based biotechnology company and Sage Therapeutics, Inc. US-based a biopharmaceutical company launched ZURZUVAE (zuranolone), a 50 mg oral treatment for postpartum depression (PPD) in women. This marks a significant advancement, addressing the underdiagnosed and undertreated condition of PPD. ZURZUVAE (zuranolone) is an oral treatment primarily used for postpartum depression (PPD) and is the first and only FDA-approved medication designed specifically for this condition.

What Are Latest Mergers And Acquisitions In The Antidepressants Market?

In December 2023, AbbVie Inc., a US-based pharmaceutical company, acquired Cerevel Therapeutics Holdings, Inc. for $8.7 billion. This strategic acquisition aims to strengthen AbbVie's capabilities in addressing complex neurological conditions and enhancing patient outcomes through improved therapeutic options. Cerevel Therapeutics Holdings, Inc. is a US-based clinical-stage biopharmaceutical company, that specializes in developing innovative therapies for disorders of the central nervous system (CNS).

Regional Insights

North America was the largest region in the antidepressants market in 2025. Middle East is expected to be the largest growing region in the global antidepressants market during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Antidepressants Market?

The antidepressants market consists of sales of duloxetine, desvenlafaxine, vilazodone, citalopram, and sertraline. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Antidepressants Market Report 2026?

The antidepressants market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the antidepressants industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.